Jury Orders Takeda, U.S. Partner to Pay $9 Million in Diabetes Drug Case

The New York Times reports that in “one of the biggest damages verdicts ever imposed,” a Louisiana jury “has ordered a Japanese drug maker and its American partner to pay a combined $9 billion in punitive damages over a diabetes drug that has been linked to cancer.” The jury in a Lafayette, LA district court “ordered the Japanese company, Takeda Pharmaceutical, to pay $6 billion in punitive damages on Monday after finding that the company had hidden the cancer risks of its drug, Actos.” The jury also ordered Takeda’s partner, Eli Lilly, “which once marketed the drug in the United States, to pay $3 billion.” Both Takeda and Lilly “said they disagreed with the verdict and would fight it.” The Times notes that the lawsuit “is one of thousands that Takeda faces over the drug, once one of the company’s best-selling products.”

From the American Association for Justice news release.

This entry was posted in Medical & Health Resources or Issues. Bookmark the permalink.

Comments are closed.